APR二季度营收7675亿韩元、营业利润1906亿韩元并上调全年销售目标至3万亿韩元

APR achieved record second-quarter earnings on the back of rapid growth in the North American and European markets. With results continuing to exceed expectations, APR raised its full-year sales guidance to 3 trillion won.
APR said in a regulatory filing on the 5th that its second-quarter consolidated revenue rose 134.2% from a year earlier to a preliminary 767.5 billion won. Operating profit over the same period increased 134.5% to 190.6 billion won. The figures topped market expectations. According to financial data provider FnGuide, APR had been expected to post revenue of 735.2 billion won and operating profit of 178.4 billion won.
With these results, APR set a new quarterly record for the second consecutive time, following the first quarter. First-half revenue reached 1.3609 trillion won, matching the company's full-year revenue of last year (1.5273 trillion won).
The company cited the growth of its cosmetics and beauty division as the driver behind the strong results. The cosmetics and beauty division recorded revenue of 648.3 billion won, up 185.5% from a year earlier, marking a record quarterly performance. Overseas operations also delivered remarkable results. Overseas revenue rose 178% year-on-year to 767.5 billion won, accounting for 92% of total revenue. Specifically, North America recorded revenue of 376.3 billion won, up 264.6% from a year earlier, while Europe posted 145.1 billion won, up 380.3%. In North America, the company strengthened its offline competitiveness by expanding its presence in online channels and at major local retailers such as Target and Walmart. In Europe, the company rapidly expanded its distribution network, focusing on five major countries—the United Kingdom, France, Germany, Italy, and Spain—by expanding its presence in key online channels such as Amazon and TikTok Shop. Asia recorded revenue of 121.1 billion won, up 14.5% from a year earlier.
APR also raised its full-year earnings guidance. In a conference call held that day, APR said, "At the beginning of the year, we set a sales target of 2.1 trillion won for this year, but reflecting the rapid growth centered on the United States and Europe, we are raising it to around 3 trillion won." The company also emphasized that it would expand into the Middle Eastern and Latin American markets. "Accompanying the president's recent visit to Brazil, we confirmed that Medicube has high brand recognition locally," the company said. "In the Middle Eastern and Latin American markets, we have confirmed that people recognize Medicube through social media such as Instagram, YouTube, and TikTok, and that a fandom around it is spreading, so there is potential for revenue to grow."
APR also unveiled the launch schedule for its new product, an energy-based device (EBD) medical device. An APR official explained, "We have completed the domestic licensing procedures and obtained approval, and we plan to proceed with procedures for domestic sales at the end of this year or early next year," adding, "We are currently verifying product performance and feedback through a medical professional network, and are additionally forming sales and manufacturing organizations." Regarding skin boosters, the company said, "Our PN (polynucleotide)-based product has completed medical device certification and export approval from the Ministry of Food and Drug Safety, so overseas sales approval has been completed," adding, "We began small-scale exports in the second quarter of this year, and overseas sales will begin in earnest from the third quarter."